Allogene Therapeutics Inc
NASDAQ:ALLO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
US |
|
T
|
TST Group Holding Ltd
TWSE:4439
|
TW |
|
Webstep ASA
OSE:WSTEP
|
NO |
|
P
|
Performance Food Group Co
F:P5F
|
US |
|
R
|
Ralph Lauren Corp
F:PRL
|
US |
|
Lincoln Electric Holdings Inc
NASDAQ:LECO
|
US |
|
B
|
BT Wealth Industries PCL
SET:BTW
|
TH |
|
P
|
Paccar Inc
XMUN:PAE
|
US |
|
M
|
MONY Group PLC
F:39M
|
UK |
|
G
|
Goodyear Thailand PCL
SET:GYT
|
TH |
|
Casta Diva Group SpA
F:99C
|
IT |
|
PRAP Japan Inc
TSE:2449
|
JP |
|
D
|
Danang Rubber JSC
VN:DRC
|
VN |
|
Cricut Inc
F:398
|
US |
|
K
|
Kingfish Company NV
OSE:KING
|
NL |
|
K
|
Korea Computer Terminal Inc
KOSDAQ:089150
|
KR |
|
Industrias Penoles SAB de CV
F:4FO
|
MX |
|
Oatly Group AB
NASDAQ:OTLY
|
SE |
|
d'Amico International Shipping SA
MIL:DIS
|
LU |
Bankruptcy Probability
Allogene Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Allogene Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
583.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
186.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
53.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Allogene Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Allogene Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.